Neomycin and polymyxin B sulfates and bacitracin zinc

Manufacturer
BUTLER ANIMAL HEALTH SUPPLY, LLC DBA COVETRUS NORTH AMERICA | Akorn Operating Company LLC | Akorn
Effective date
2022-02-02
Label type
PRESCRIPTION ANIMAL DRUG LABEL
Version
2
Source
legacy-cache
Hydrated at
2026-08-01 22:10:00

Label at a glance#

ProductNeomycin and polymyxin B sulfates and bacitracin zinc
Active ingredientpolymyxin B sulfate, neomycin sulfate, bacitracin zinc
Label structure12 sections

Dosage and administration

Properly cleanse area to be treated. Foreign bodies, crusted exudates and debris should be carefully removed. Express a small quantity of ointment into the conjunctival sac beneath the lower eyelid three or four times daily. After application hold the eyelids shut for a short time so that a thin film of ointment covers the cornea.

Storage and handling

Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temp]. KEEP OUT OF REACH OF CHILDREN. Not for Human Use. CAUTION: Federal (U.S.A.) law restricts this drug to use by or on the order of a licensed veterinarian. Warning: Serious hypersensitivity (anaphylactic) reactions have been reported in cats within 4 hours of application of antibiotic ophthalmic preparations. Some of these reactions have resulted in ...

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

ANADA 200-553, Approved by FDA

DESCRIPTION:

DESCRIPTION SECTION

Each gram contains: polymyxin B sulfate 10,000 units, bacitracin zinc 400 units, neomycin sulfate 5 mg (equivalent to 3.5 mg neomycin base) in a white petrolatum base, q.s.

ACTIONS:

SPL UNCLASSIFIED SECTION

Polymyxin B is one of a group of closely related substances produced by various strains of Bacillus polymyxa. The activity of polymyxin B is sharply restricted to gram-negative bacteria. Neomycin, isolated from Streptomyces fradiae, has antibacterial activity in vitro against a wide range of gram-negative and gram-positive organisms. Bacitracin, an antibiotic substance derived from cultures of Bacillus subtilis (Tracy), exerts antibacterial action in vitro against a variety of gram-positive and a few gram-negative organisms.

INDICATIONS:

INDICATIONS & USAGE SECTION

This product is indicated for the treatment of superficial bacterial infections of the eyelid and conjunctiva of dogs and cats when due to organisms susceptible to one or more of the antibiotics contained in the ointment.

Laboratory tests should be conducted including in vitro culturing and susceptibility tests on samples collected prior to treatment.

PRECAUTIONS:

PRECAUTIONS SECTION

If irritation develops discontinue treatment with this drug. If there is no response to treatment in 2 to 3 days, discontinue treatment and re-evaluate diagnosis. Prolonged use may result in overgrowth of nonsusceptible organisms, including fungi.

Care should be taken not to contaminate the applicator tip during administration of the preparation.

ADVERSE REACTIONS:

ADVERSE REACTIONS SECTION

Adverse reactions, such as itching, burning, or inflammation may occur in animals sensitive to this product.

DOSAGE AND ADMINISTRATION:

DOSAGE & ADMINISTRATION SECTION

Properly cleanse area to be treated. Foreign bodies, crusted exudates and debris should be carefully removed. Express a small quantity of ointment into the conjunctival sac beneath the lower eyelid three or four times daily. After application hold the eyelids shut for a short time so that a thin film of ointment covers the cornea.

HOW SUPPLIED:

HOW SUPPLIED SECTION

NDC 11695-6841-3

Tube of 3.5 g (1/8 oz) with ophthalmic tip.

STORAGE:

STORAGE AND HANDLING SECTION

Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temp].

KEEP OUT OF REACH OF CHILDREN.

Not for Human Use.

CAUTION: Federal (U.S.A.) law restricts this drug to use by or on the order of a licensed veterinarian.

Warning: Serious hypersensitivity (anaphylactic) reactions have been reported in cats within 4 hours of application of antibiotic ophthalmic preparations. Some of these reactions have resulted in death.

covetrus®

Questions?

SPL UNCLASSIFIED SECTION

(855) 724-3461

Distributed by:
Covetrus North America
400 Metro Place North
Dublin, OH 43017

covetrus.com

HNPB00N   REV. 0121       AH-071986-01

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Principal Display Panel Text for Container Label:

Covetrus logo Reorder #071986

NDC 11695-6841-3

Neomycin and polymyxin B sulfates, and

bacitracin zinc ophthalmic ointment, USP

For veterinary use only ANADA 200-553, Approved by FDA

Sterile ophthalmic ointment Rx only Net Wt. 3.5 g (1/8 oz.)

Principal Display Panel Text for Container Label
Principal Display Panel Text for Container Label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Principal Display Panel Text for Carton Label:

Covetrus logo Reorder #071986

NDC 11695-6841-3

Neomycin and polymyxin B sulfates, and

bacitracin zinc ophthalmic ointment, USP

Sterile Ophthalmic Ointment For veterinary use only Rx only

Net Wt. 3.5 g (1/8 oz.) ANADA 200-553, Approved by FDA

Principal Display Panel Text for Carton Label
Principal Display Panel Text for Carton Label

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 9 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
11695-684111695-6841-3

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 4 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 10 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Polymyxin BPOLYMYXIN B SULFATEXellia Pharmaceuticals USA LLCb56f18c0-ef5e-4ed9-a5af-f79f3cd189b62026-06-22Boxed warning, Warnings, Adverse reactionsName fallback
generic name: POLYMYXIN B SULFATE
Polymyxin BPOLYMYXIN B SULFATESagent Pharmaceuticals7dc505aa-64b0-4b7f-8ee3-2945bde40a342025-10-01Boxed warning, Warnings, Adverse reactionsName fallback
generic name: POLYMYXIN B SULFATE
POLYMYXIN BPOLYMYXIN B SULFATEFOSUN PHARMA USA INCfd664927-db58-a1af-e053-6294a90a90482025-05-29Boxed warning, Warnings, Adverse reactionsName fallback
generic name: POLYMYXIN B SULFATE
Polymyxin BPOLYMYXIN B SULFATEHikma Pharmaceuticals USA Inc.d2bf65f6-2763-4859-a665-ad5e6cde71ee2025-05-23Boxed warning, Warnings, Adverse reactionsName fallback
generic name: POLYMYXIN B SULFATE
POLYMYXIN BPOLYMYXIN B SULFATEGland Pharma Limiteddc74dee2-1d0b-4fab-a29b-1755fdb5da752025-05-09Boxed warning, Warnings, Adverse reactionsName fallback
generic name: POLYMYXIN B SULFATE
Neomycin and Polymyxin B Sulfates and Bacitracin ZincNEOMYCIN SULFATE, POLYMYXIN B SULFATE AND BACITRACIN ZINCBausch & Lomb Incorporatedf3231f1c-665e-4efa-baa1-83bf296b2f8f2025-01-02Warnings, Adverse reactionsName fallback
brand name: Neomycin and Polymyxin B Sulfates and Bacitracin Zinc
Polymyxin BPOLYMYXIN B SULFATEFresenius Kabi USA, LLC72dd6de6-31d6-4a8f-881b-91af91ed93142022-12-01Boxed warning, Warnings, Adverse reactionsName fallback
generic name: POLYMYXIN B SULFATE
Polymyxin BPOLYMYXIN B SULFATEHikma Pharmaceuticals USA Inc.18daf0d1-b6f5-46f4-ab2f-01a594f3959c2022-04-28Boxed warning, Warnings, Adverse reactionsName fallback
generic name: POLYMYXIN B SULFATE
POLYMYXIN BPOLYMYXIN B SULFATEFresenius Kabi USA, LLC704a41f5-b109-4c16-8d3e-1495c99179522021-05-31Boxed warning, Warnings, Adverse reactionsName fallback
generic name: POLYMYXIN B SULFATE
POLYMYXIN BPOLYMYXIN B SULFATEFresenius Kabi USA, LLCfbc12c18-567b-41bc-89d0-efd29616615c2021-02-28Boxed warning, Warnings, Adverse reactionsName fallback
generic name: POLYMYXIN B SULFATE

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.